>_ QFI Terminal
Terminal › Stocks › CHE

Chemed Corporation (CHE) Stock

Healthcare · Medical - Care Facilities · US
$550.62 +1.13%
Last updated Nov 12, 2026 09:31 UTC

CHE Key Statistics

Market Cap$7.17B
P/E (TTM)26.32
P/S (TTM)2.69
P/B (TTM)8.35
Revenue (TTM)$2.66B
EPS (TTM)$20.92
Dividend Yield0.49%
ROE (TTM)32.10%
Net Margin10.61%
Gross Margin33.54%
52W High$562.24
52W Low$365.25
Analyst ViewBuy
Price Target$635.00
Employees15,811
Volume141,224

About Chemed Corporation

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

CEO: Kevin J. McNamara. Company website

CHE — Frequently Asked Questions

What is the CHE stock price today?

Chemed Corporation (CHE) trades at $550.62, up 1.13% on the day, as of Nov 12, 2026 09:31 UTC.

What is Chemed Corporation's market cap?

Chemed Corporation has a market capitalisation of $7.17B, calculated from the live CHE share price and shares outstanding.

What is the P/E ratio of CHE?

CHE trades at a trailing P/E of 26.32, from earnings per share of $20.92 over the last twelve months.

How much revenue does Chemed Corporation make?

Chemed Corporation generated revenue of $2.66B over the trailing twelve months, which puts the stock at 2.69 times sales.

Does CHE pay a dividend?

Yes. Chemed Corporation pays a dividend yielding 0.49% on the current share price.

What is the 52-week range for CHE?

CHE has traded between $365.25 and $562.24 over the past 52 weeks, and the last price is 2.1% below that high.

Is Chemed Corporation profitable?

Yes. Chemed Corporation keeps 10.61% of revenue as net income over the trailing twelve months.

What is the analyst price target for CHE?

Wall Street analysts rate CHE Buy, with an average price target of $635.00, 15.3% above the current price.

What sector is Chemed Corporation in?

Chemed Corporation is classified under the Healthcare sector and the Medical - Care Facilities industry, and is domiciled in US.

Who is the CEO of Chemed Corporation?

Kevin J. McNamara is the chief executive of Chemed Corporation, which employs 15,811 people.

Where can I track CHE in real time?

QFI Terminal shows CHE with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See CHE live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open CHE in Terminal See plans

Medical - Care Facilities stocks

HCA HCA Healthcare, Inc. THC Tenet Healthcare Corporation FMS Fresenius Medical Care AG & Co. KGaA UHS Universal Health Services, Inc. DVA DaVita Inc. CYH Community Health Systems, Inc. EHC Encompass Health Corporation ENSG The Ensign Group, Inc. SEM Select Medical Holdings Corporation ACHC Acadia Healthcare Company, Inc. HIMS Hims & Hers Health, Inc. MD Pediatrix Medical Group, Inc. HCSG Healthcare Services Group, Inc. USPH U.S. Physical Therapy, Inc. JYNT The Joint Corp.

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. CNC Centene Corp. ELV Elevance Health Inc. HUM Humana Inc. JNJ Johnson & Johnson LLY Eli Lilly and Company MRK Merck & Co., Inc. ABBV AbbVie Inc. PFE Pfizer Inc. AZN AstraZeneca PLC NVS Novartis AG SNY Sanofi BMY Bristol-Myers Squibb Company ABT Abbott Laboratories TMO Thermo Fisher Scientific Inc. MOH Molina Healthcare, Inc. AMGN Amgen Inc. MDT Medtronic Plc GSK GSK plc

ETFs holding CHE

VIG Vanguard Dividend Appreciation ETF 0.03% VYM Vanguard High Dividend Yield ETF 0.03% SCHG Schwab U.S. Large-Cap Growth ETF 0.02% IWD iShares Russell 1000 Value ETF 0.02% SCHX Schwab U.S. Large-Cap ETF 0.01% IWB iShares Russell 1000 ETF 0.01% SCHB Schwab U.S. Broad Market ETF 0.01% VTI Vanguard Morningstar Total Stock Market ETF 0.01% DGRO iShares Core Dividend Growth ETF 0.01% VT Vanguard Total World Stock ETF 0.01%

Largest institutional holders of CHE

BlackRock, Inc. BLK 1,484,282 shares
AQR CAPITAL MANAGEMENT LLC 972,474 shares
VANGUARD PORTFOLIO MANAGEMENT LLC 787,068 shares
VANGUARD CAPITAL MANAGEMENT LLC 604,420 shares
ACADIAN ASSET MANAGEMENT LLC 461,748 shares
STATE STREET CORP STT 444,716 shares
JPMORGAN CHASE & CO JPM 403,395 shares
GEODE CAPITAL MANAGEMENT, LLC 402,055 shares
Boston Partners 376,995 shares
Advisors Asset Management, Inc. 335,466 shares

CHE insiders on other boards

JBLU JetBlue Airways Corporation McCarthy Eileen P